Design, Synthesis and In Vitro Release Studies of Co-Drugs for Rheumatoid Arthritis

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|14|1|47-52

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.14, Iss.1, 2015-02, pp. : 47-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for rheumatoid arthritis

By Voulgari Paraskevi V  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 175-196

Informa Healthcare

Access to resources Recommend Favorite

Synthesis of nicotinamide-based molecularly imprinted microspheres and in vitro controlled release studies

By Sole Roberta Del   Lazzoi Maria Rosaria   Vasapollo Giuseppe  

Drug Delivery, Vol. 17, Iss. 3, 2010-04 ,pp. : 130-137

Informa Healthcare

Access to resources Recommend Favorite

Newer drugs for rheumatoid arthritis worth their cost?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

By Avouac J   Allanore Y  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1121-1128

Informa Healthcare

Access to resources Recommend Favorite

Newer Immunosuppressive Drugs: Their Potential Role in Rheumatoid Arthritis Therapy

By Drosos A.A.  

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 891-907

Adis International

Access to resources Recommend Favorite